Cargando…
Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index
Autores principales: | Shao, Ting, Chen, Tianzhi, Chen, Yuning, Liu, Xiaoyue, Chen, Yi-Li, Wang, Qi, Zhu, Tong, Guo, Maojun, Li, Hui, Ju, Dianwen, Wang, Chunhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391632/ https://www.ncbi.nlm.nih.gov/pubmed/32728048 http://dx.doi.org/10.1038/s41392-020-00247-y |
Ejemplares similares
-
Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics
por: Umstätter, Florian, et al.
Publicado: (2022) -
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin‐Targeted Conjugate
por: Raposo Moreira Dias, André, et al.
Publicado: (2018) -
Self‐Stabilized Supramolecular Assemblies Constructed from PEGylated Dendritic Peptide Conjugate for Augmenting Tumor Retention and Therapy
por: Zheng, Xiuli, et al.
Publicado: (2021) -
Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021) -
Computational Construction of Antibody–Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker
por: Filntisi, Arianna, et al.
Publicado: (2014)